Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹30,681.9
₹65,197 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,695.1
₹33,665 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹486.3
₹7,653 Cr
Pharmaceuticals & Drugs
₹734.0
₹6,653 Cr
Pharmaceuticals & Drugs
₹291.9
₹3,265 Cr
Pharmaceuticals & Drugs
₹357.5
₹3,262 Cr
Pharmaceuticals & Drugs
₹103.8
₹2,666 Cr
Pharmaceuticals & Drugs
₹857.6
₹489 Cr
Pharmaceuticals & Drugs
₹73.4
₹357 Cr
Pharmaceuticals & Drugs
₹56.3
₹160 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,695.1
₹4,532 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹486.3
₹4,145 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹357.5
₹2,330 Cr
Pharmaceuticals & Drugs
₹734.0
₹2,057 Cr
Pharmaceuticals & Drugs
₹291.9
₹628 Cr
Pharmaceuticals & Drugs
₹103.8
₹211 Cr
Pharmaceuticals & Drugs
₹30,681.9
₹6,243 Cr
Pharmaceuticals & Drugs
₹73.4
₹51 Cr
Pharmaceuticals & Drugs
₹857.6
₹360 Cr
Pharmaceuticals & Drugs
₹56.3
₹576 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,695.1
₹898 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹486.3
₹389 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹734.0
₹249 Cr
Pharmaceuticals & Drugs
₹357.5
₹153 Cr
Pharmaceuticals & Drugs
₹103.8
₹142 Cr
Pharmaceuticals & Drugs
₹291.9
₹137 Cr
Pharmaceuticals & Drugs
₹30,681.9
₹1,334 Cr
Pharmaceuticals & Drugs
₹73.4
₹2 Cr
Pharmaceuticals & Drugs
₹857.6
₹40 Cr
Pharmaceuticals & Drugs
₹56.3
₹6 Cr

You may also like the below Video Courses